Tanmayi Mankame
Director, Scientific Communications - Hematology/Oncology & Early Pipeline, Gilead
Graduation Year: 2012
Thesis: RB Transcriptionally Activates the Anti-angiogenic Protein NOL7
Advisor: Mark Lingen
Director, Scientific Communications - Hematology/Oncology & Early Pipeline, Gilead